194 related articles for article (PubMed ID: 30509104)
1. MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4.
Na XY; Shang XS; Zhao Y; Ren PP; Hu XQ
Neoplasma; 2019 Mar; 66(2):211-221. PubMed ID: 30509104
[TBL] [Abstract][Full Text] [Related]
2. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
[TBL] [Abstract][Full Text] [Related]
3. MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG.
An N; Zheng B
Technol Cancer Res Treat; 2020; 19():1533033819898729. PubMed ID: 32301392
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
[TBL] [Abstract][Full Text] [Related]
6. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer.
Majid S; Dar AA; Saini S; Deng G; Chang I; Greene K; Tanaka Y; Dahiya R; Yamamura S
PLoS One; 2013; 8(7):e67686. PubMed ID: 23844063
[TBL] [Abstract][Full Text] [Related]
8. miR-802 inhibits the proliferation, invasion, and epithelial-mesenchymal transition of glioblastoma multiforme cells by directly targeting SIX4.
Huang W; Shi Y; Han B; Wang Q; Zhang B; Qi C; Liu F
Cell Biochem Funct; 2020 Jan; 38(1):66-76. PubMed ID: 31702057
[TBL] [Abstract][Full Text] [Related]
9. SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression.
Wang L; Zhang Z; Yu X; Li Q; Wang Q; Chang A; Huang X; Han X; Song Y; Hu J; Pang L; Hou J; Li F
Cancer Lett; 2020 Jan; 468():14-26. PubMed ID: 31600529
[TBL] [Abstract][Full Text] [Related]
10. HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells.
Wang L; Tong D; Guo Q; Wang X; Wu F; Li Q; Yang J; Zhao L; Qin Y; Liu Y; Huang C
Sci Rep; 2018 Feb; 8(1):2431. PubMed ID: 29402992
[TBL] [Abstract][Full Text] [Related]
11. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
[TBL] [Abstract][Full Text] [Related]
12. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-328-3p inhibits the tumorigenesis of bladder cancer through targeting ITGA5 and inactivating PI3K/AKT pathway.
Yan T; Ye XX
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5139-5148. PubMed ID: 31298367
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of MiR-203a Disinhibits Bmi1 and Promotes Growth and Proliferation of Keratinocytes in Cholesteatoma.
Zang J; Hui L; Yang N; Yang B; Jiang X
Int J Med Sci; 2018; 15(5):447-455. PubMed ID: 29559833
[No Abstract] [Full Text] [Related]
15. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of miR-29c in human bladder cancer and the inhibition of proliferation in T24 cell via PI3K-AKT pathway.
Fan Y; Song X; Du H; Luo C; Wang X; Yang X; Wang Y; Wu X
Med Oncol; 2014 Jul; 31(7):65. PubMed ID: 24952510
[TBL] [Abstract][Full Text] [Related]
17. [Effects of long non-coding RNA FLJ37505 on the proliferation and migration of bladder cancer cells].
Xiang H; Liu Z; Zhou YB; Yao Q; Jin L; Xue BX
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(16):1249-1254. PubMed ID: 32344498
[No Abstract] [Full Text] [Related]
18. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
[TBL] [Abstract][Full Text] [Related]
19. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
Li Y; Ma X; Wang Y; Li G
Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
[TBL] [Abstract][Full Text] [Related]
20. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T
J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
